

Success against sickle-cell would be “the first genetic cure of a common genetic disease” and could free tens of thousands of Americans from agonizing pain
Quick ReadSuccess against sickle-cell would be “the first genetic cure of a common genetic disease” and could free tens of thousands of Americans from agonizing pain
Quick Read
Sickle-Cell Patients See Hope in CRISPRAugust 23, 2017 |
The disease may be among the first to be treated with the novel gene-editing tool
Quick ReadSo far, gene therapy has only treated rare disorders. Now, for the first time, it has been used to treat a boy with sickle cell disease, a common genetic disease
Quick ReadResearchers have cleared the last scientific hurdle to a clinical trial of gene therapy to cure sickle cell disease, they reported on Tuesday, fueling hopes that they will begin enrolling patients early next year. But they dodged a bullet
Quick Read
The Quality of Nursing Care for Sickle Cell DiseaseJuly 8, 2015 |
Q & A with Johns Hopkins Catalyst Award Winner Carlton Haywood Jr about his intervention designed to improve healthcare provider attitudes and beliefs about patients with sickle cell disease
Read More
Carlton Haywood Jr. Named to Ebony Power 100 ListNovember 25, 2014 |
Bioethics scholar and sickle cell disease researcher Carlton Haywood Jr. has been recognized by Ebony Magazine on its Power 100 list
Read More
A Vision of Hope for Young PatientsNovember 18, 2014 |
Berman Institute Scholars launch a curriculum for training diverse healthcare workers to apply palliative care principles to pediatric patients suffering from sickle cell disease and Duchenne muscular dystrophy
Read More
Some Sickle Cell Patients Miss Out on TreatmentSeptember 10, 2014 |
Sickle cell disease patients are less likely to follow physician recommendations when they perceive discrimination, study finds. Authors include our Carlton Haywood Jr, and Mary Catherine Beach
Read More